• Surgical Techniques and Technologies

    Read Issue
  • Topcon Euretina 2018

    Clinical Advances and Applications With Swept Source OCT and Angiography.

    Read Article
  • 2RT: Earlier Intervention for AMD

    As multimodal imaging redefines diagnosis, a new laser technology may make early interventional treatment possible for some types of AMD.

    Read Article
  •  
     
  • Diabetic Retinopathy
  • Retinal Disease Awareness News
  • DME Disease Education Resource Center
  • Uveitis Resource Center
  • ZEISS OCT Angiography eNewsletter Series
  • AMD Disease Education Resource Center
  • diabetes awareness month
  • wet age-related macular degeneration month
  • Articles From This Issue

     

    UP FRONT

    Medical Editors’ Page

    Back To Our Surgical Roots

    At the Atlantic Coast Retina Club/MACULA 2019 meeting, held January 10-12 in Boston, a number of presenters commented on how the passion of a particular generation of retina…

    Retina News

    Phase 2/3 Trial Planned for LCA Gene Therapy ProQR Therapeutics has reached agreement with the US FDA on the design of a phase 2/3 clinical trial of the company’s RNA-ba…

    VISUALLY SPEAKING

    Posterior Segment Firecracker Injury

    A 26-year-old Indian man presented with sudden loss of vision, pain, and swelling of the right eye after a blast injury from a firecracker while celebrating Diwali (Figure 1).…

     

    Supplements and Inserts

    NEWS


     

    Researchers Test Stem Cell–Based Retinal Implant for Dry AMD With Encouraging Results

    Physicians and researchers at the USC Roski Eye Institute have collaborated with other California institutions to show that a first-in-kind stem cell-based retinal implant is feasible for us…

    GenSight Biologics Announces Topline Results from Phase 3 Clinical Trial of GS010 in Patients with Leber Hereditary Optic Neuropathy (LHON)

    GenSight Biologics announced that a phase 3 study of GS010 (rAAV2/2-ND4) in patients with Leber hereditary optic neuropathy (LHON) failed to meet its primary endpoint, with sham-treated eyes demonstra…

    Treat-Extend-Stop Protocol for Wet AMD: Long-term Outcomes

    A retrospective chart review was performed for 71 eyes of 67 patients with neovascular age-related macular degeneration (AMD) treated with intravitreal anti-vascular endothelial growth factor (VEGF) i…

    Patients Regain Sight After Being First to Get Retinal Tissue Engineered From Stem Cells

    The first patients to receive a new treatment derived from stem cells for people with wet age-related macular degeneration (AMD) have regained reading vision, according to a report in VisionMonday. Th…

    Contact Info

    Bryn Mawr Communications LLC
    1008 Upper Gulph Road, Suite 200
    Wayne, PA 19087

    Phone: 484-581-1800
    Fax: 484-581-1818

    Scott Krzywonos
    Editor-in-Chief
    484-581-1880
    skrzywonos@bmctoday.com

    Janet Burk
    Publisher
    214-394-3551
    jburk@bmctoday.com

    About Retina Today

    Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.